Cardiac Changes After Effective Dose Carbetocin for Elective Caesarian Section
A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 200 participants.
Also called NCT06946589
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 200 participants
- Sponsor
- Jordan Leitch
- Registry
-
NCT06946589
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Canada
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT06946589. Randomized; double masking; primary purpose treatment. Start 2025-08-01 (anticipated); primary completion 2026-08-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Cardiac Changes After Effective Dose Carbetocin for Elective Caesarian Section
- Condition
- Cardiac Ischemia
- Condition
- Cesarian Section
- Intervention (Drug)
- Carbetocin
- Lead sponsor
- Jordan Leitch
Record details
- Record id
cardio:ct-nct06946589- Content hash
8b97ad956274849d56c7e71aa77b2f3f383f6063e95297067adb995921dc95a7